Phathom Pharmaceuticals Inc (PHAT)
10.27
-0.13
(-1.25%)
USD |
NASDAQ |
Jun 28, 16:00
10.31
+0.04
(+0.39%)
After-Hours: 20:00
Phathom Pharmaceuticals Free Cash Flow: -168.39M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -168.39M |
| December 31, 2023 | -139.21M |
| September 30, 2023 | -136.40M |
| June 30, 2023 | -138.69M |
| March 31, 2023 | -142.63M |
| December 31, 2022 | -147.57M |
| September 30, 2022 | -147.48M |
| June 30, 2022 | -141.41M |
| March 31, 2022 | -143.68M |
| Date | Value |
|---|---|
| December 31, 2021 | -148.78M |
| September 30, 2021 | -135.75M |
| June 30, 2021 | -127.58M |
| March 31, 2021 | -108.57M |
| December 31, 2020 | -70.73M |
| September 30, 2020 | -65.89M |
| June 30, 2020 | -52.12M |
| March 31, 2020 | -73.05M |
| December 31, 2019 | -36.51M |
Free Cash Flow Range, Past 5 Years
-168.39M
Minimum
Mar 2024
-36.51M
Maximum
Dec 2019
-118.02M
Average
-137.54M
Median
Free Cash Flow Benchmarks
| Insmed Inc | -588.55M |
| Regeneron Pharmaceuticals Inc | 3.930B |
| Rocket Pharmaceuticals Inc | -209.70M |
| Rhythm Pharmaceuticals Inc | -140.47M |
| Biomea Fusion Inc | -105.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -69.02M |
| Cash from Investing (Quarterly) | -0.04M |
| Cash from Financing (Quarterly) | 9.90M |
| Free Cash Flow Per Share (Quarterly) | -1.183 |
| Free Cash Flow to Equity (Quarterly) | -80.24M |
| Free Cash Flow Yield | -29.67% |